We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Manhattan Pharmaceuticals has begun dosing patients in its first Phase I trial
in Basel, Switzerland, to evaluate the safety and tolerability of defined
doses of orally administered Oleoyl estrone (OE) in obese adults.
Generex Biotechnology has reported results of a preliminary Phase IIb clinical
study of Oral-lyn, the company's proprietary oral insulin spray formulation.
Millennium Pharmaceuticals has announced results from two clinical trials with
Velcade in patients with non-Hodgkin's lymphoma (NHL) published in the Journal
of Clinical Oncology (JCO).
Xcyte Therapies has withdrawn its submission to the FDA of the clinical protocol
for a planned Phase II/III trial of Xcellerated T Cells in chronic lymphocytic
leukemia.
Gilead Sciences has announced preliminary 48-week data from the company's Study
934, which was designed to compare a regimen of Viread, Emtriva and Bristol-Myers
Squibb's Sustiva to Combivir and Sustiva in treatment-naive patients with HIV.
Join FDAnews Feb. 24 to learn about "Drug Marketing Practices in
Europe: Navigating Tough Rules and New Enforcement," a 90-minute, interactive
audio alert. Hear former FDA official Linda Horton, now an attorney with
Hogan & Hartson, explain how the new EU Community Code on Medicinal Products
affects your marketing activities, including your relationship with health professionals.
On Feb. 25, receive a concise and expert analysis of the "Medicare Part
D for Drugmakers: New Requirements, New Risks, New Markets," presented
in a 90-minute audio alert by Keith Korenchuk of McGuireWoods and Sheryl
Vacca of Deloitte & Touche.
Sequenom has announced the discovery of genetic variations in the gene
encoding the nuclear mitotic apparatus protein (NuMA) that affect breast cancer
risk.
GTx has initiated a Phase I clinical trial for ostarine, GTx's second selective
androgen receptor modulator (SARM) compound to be tested in clinical trials.